The Sirtuin Domain Name Collection is for Sale

Share Article

The seven sirtuin genes (Sirt 1-7) are promising targets for anti-aging drugs being developed by biotech and pharmaceutical companies. The sirtuin domain name collection -,,,,,, and - is valuable intellectual property and is now available for sale.

Humans (and other mammals) have seven sirtuin genes (Sirt 1 – 7). Studies have shown that affecting one or more of these genes (which can be accomplished using novel pharmaceutical entities or natural compounds such as resveratrol) can have a positive effect on health. Sirtuin research has focused on combating diseases of aging including:

  •     Heart Disease,
  •     Type 2 Diabetes,
  •     Cancer,
  •     Alzheimer’s Disease, and,
  •     Osteoporosis

The sirtuin collection -,,,,,, and - is valuable intellectual property for pharmaceutical or biotech companies focused on developing anti-aging drugs (it should be noted that in the last year, Google has formed the California Life Company (Calico) (which recently announced a $500 million partnership with Abbvie) and biologist Craig Venter and partner Peter Diamandis have founded Human Longevity Inc. – these companies (in addition to GlaxoSmithKline, Novartis, and other large pharmaceutical companies) are pursuing drugs to fight diseases of aging). For their part, the seven sirtuins are likely to play a significant role in these drug development efforts.

To inquire about these domains, please email domains(at)sirt1(dot)com or call (919) 641-7542.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

J Stubbs
Resviva, LLC
+1 (919) 641-7542
Email >